The #IMPORTANTproject joined the 2nd #HorizonEurope Cancer Mission “Diagnosis & Treatment” Cluster Meeting in Berlin 🇩🇪
We shared actions on #CitizenEngagement & #AddressingInequalities in cancer care highlighting how we bring science closer to people.
#MissionCancer #CancerResearch #HaDEA
We shared actions on #CitizenEngagement & #AddressingInequalities in cancer care highlighting how we bring science closer to people.
#MissionCancer #CancerResearch #HaDEA
October 29, 2025 at 1:57 PM
The #IMPORTANTproject joined the 2nd #HorizonEurope Cancer Mission “Diagnosis & Treatment” Cluster Meeting in Berlin 🇩🇪
We shared actions on #CitizenEngagement & #AddressingInequalities in cancer care highlighting how we bring science closer to people.
#MissionCancer #CancerResearch #HaDEA
We shared actions on #CitizenEngagement & #AddressingInequalities in cancer care highlighting how we bring science closer to people.
#MissionCancer #CancerResearch #HaDEA
The IMPORTANT Patient Companion was presented by Maryam Yeganeh (FHNW) at AI Open House Basel, an event with more than 100 participants
Showcasing patient-centred healthcare navigation & decision-making through digital innovation
#IMPORTANTProject #DigitalHealth #PatientCentredCare #EUCancerMission
Showcasing patient-centred healthcare navigation & decision-making through digital innovation
#IMPORTANTProject #DigitalHealth #PatientCentredCare #EUCancerMission
September 29, 2026 at 9:57 AM
The IMPORTANT Patient Companion was presented by Maryam Yeganeh (FHNW) at AI Open House Basel, an event with more than 100 participants
Showcasing patient-centred healthcare navigation & decision-making through digital innovation
#IMPORTANTProject #DigitalHealth #PatientCentredCare #EUCancerMission
Showcasing patient-centred healthcare navigation & decision-making through digital innovation
#IMPORTANTProject #DigitalHealth #PatientCentredCare #EUCancerMission
IMPORTANT at the Nordic Congress on Breast Cancer 2026!
Prof. Antonis Valachis presented IMPORTANT as an example of treatment optimisation during his talk "Treatment reduction–safe or risky?"
The right dose, for the right patient, at the right time
#IMPORTANTProject #BreastCancer #EUCancerMission
Prof. Antonis Valachis presented IMPORTANT as an example of treatment optimisation during his talk "Treatment reduction–safe or risky?"
The right dose, for the right patient, at the right time
#IMPORTANTProject #BreastCancer #EUCancerMission
September 29, 2026 at 8:03 AM
IMPORTANT at the Nordic Congress on Breast Cancer 2026!
Prof. Antonis Valachis presented IMPORTANT as an example of treatment optimisation during his talk "Treatment reduction–safe or risky?"
The right dose, for the right patient, at the right time
#IMPORTANTProject #BreastCancer #EUCancerMission
Prof. Antonis Valachis presented IMPORTANT as an example of treatment optimisation during his talk "Treatment reduction–safe or risky?"
The right dose, for the right patient, at the right time
#IMPORTANTProject #BreastCancer #EUCancerMission
🎥 New video: Why dose optimisation matters for older people with advanced breast cancer.
The IMPORTANT project is studying CDK4/6 inhibitor dosing strategies to improve tolerability, quality of life, and shared decision-making in treatment.
#IMPORTANTproject #BreastCancer #HorizonEurope
The IMPORTANT project is studying CDK4/6 inhibitor dosing strategies to improve tolerability, quality of life, and shared decision-making in treatment.
#IMPORTANTproject #BreastCancer #HorizonEurope
March 12, 2026 at 10:14 AM
🎥 New video: Why dose optimisation matters for older people with advanced breast cancer.
The IMPORTANT project is studying CDK4/6 inhibitor dosing strategies to improve tolerability, quality of life, and shared decision-making in treatment.
#IMPORTANTproject #BreastCancer #HorizonEurope
The IMPORTANT project is studying CDK4/6 inhibitor dosing strategies to improve tolerability, quality of life, and shared decision-making in treatment.
#IMPORTANTproject #BreastCancer #HorizonEurope
The #IMPORTANTProject will join the #EUnetCCC Symposium on Cancer Treatment De-escalation
📅 5–6 March 2026
📍 NKI, Amsterdam
Proud to contribute to the discussion on personalised dose optimisation for older patients with advanced HR+/HER2- breast cancer
#DeEscalation #HorizonEurope #EUCancerMission
📅 5–6 March 2026
📍 NKI, Amsterdam
Proud to contribute to the discussion on personalised dose optimisation for older patients with advanced HR+/HER2- breast cancer
#DeEscalation #HorizonEurope #EUCancerMission
February 18, 2026 at 8:27 AM
The #IMPORTANTProject will join the #EUnetCCC Symposium on Cancer Treatment De-escalation
📅 5–6 March 2026
📍 NKI, Amsterdam
Proud to contribute to the discussion on personalised dose optimisation for older patients with advanced HR+/HER2- breast cancer
#DeEscalation #HorizonEurope #EUCancerMission
📅 5–6 March 2026
📍 NKI, Amsterdam
Proud to contribute to the discussion on personalised dose optimisation for older patients with advanced HR+/HER2- breast cancer
#DeEscalation #HorizonEurope #EUCancerMission
📢 New publication from #IMPORTANTProject!
The partner University of Patras has published new research exploring how digital twins, mechanistic modelling & AI can support more personalised approaches in geriatric oncology & care for older people with cancer.
🔗 www.frontiersin.org/journals/art...
The partner University of Patras has published new research exploring how digital twins, mechanistic modelling & AI can support more personalised approaches in geriatric oncology & care for older people with cancer.
🔗 www.frontiersin.org/journals/art...
Frontiers | From mechanistic models to artificial intelligence: exploring the potential of digital twins in geriatric oncology
This survey explores how machine learning and artificial intelligence (AI) can be integrated with mechanistic models to create more accurate, dynamic, predic...
doi.org
August 18, 2026 at 11:29 AM
📢 New publication from #IMPORTANTProject!
The partner University of Patras has published new research exploring how digital twins, mechanistic modelling & AI can support more personalised approaches in geriatric oncology & care for older people with cancer.
🔗 www.frontiersin.org/journals/art...
The partner University of Patras has published new research exploring how digital twins, mechanistic modelling & AI can support more personalised approaches in geriatric oncology & care for older people with cancer.
🔗 www.frontiersin.org/journals/art...
🎯Optimising treatment for older patients with metastatic #BreastCancer
Watch here: lnkd.in/dGzPDhBv
🔬The #IMPORTANTProject aims to optimise CDK4/6 inhibitor dosing through a multinational clinical trial integrating geriatric assessment–based strategies
🎗️Older patients deserve evidence-based care
Watch here: lnkd.in/dGzPDhBv
🔬The #IMPORTANTProject aims to optimise CDK4/6 inhibitor dosing through a multinational clinical trial integrating geriatric assessment–based strategies
🎗️Older patients deserve evidence-based care
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
February 11, 2026 at 7:49 AM
🎯Optimising treatment for older patients with metastatic #BreastCancer
Watch here: lnkd.in/dGzPDhBv
🔬The #IMPORTANTProject aims to optimise CDK4/6 inhibitor dosing through a multinational clinical trial integrating geriatric assessment–based strategies
🎗️Older patients deserve evidence-based care
Watch here: lnkd.in/dGzPDhBv
🔬The #IMPORTANTProject aims to optimise CDK4/6 inhibitor dosing through a multinational clinical trial integrating geriatric assessment–based strategies
🎗️Older patients deserve evidence-based care
IMPORTANT Newsletter #21 is out!
All 16 trial sites are open for recruitment, with 146 patients included and 134 randomized as of 31 August 2026
Read the latest updates from the IMPORTANT project
important-project.com
#IMPORTANTProject #HorizonEurope #BreastCancer #ClinicalTrials #GeriatricOncology
All 16 trial sites are open for recruitment, with 146 patients included and 134 randomized as of 31 August 2026
Read the latest updates from the IMPORTANT project
important-project.com
#IMPORTANTProject #HorizonEurope #BreastCancer #ClinicalTrials #GeriatricOncology
September 17, 2026 at 7:50 AM
IMPORTANT Newsletter #21 is out!
All 16 trial sites are open for recruitment, with 146 patients included and 134 randomized as of 31 August 2026
Read the latest updates from the IMPORTANT project
important-project.com
#IMPORTANTProject #HorizonEurope #BreastCancer #ClinicalTrials #GeriatricOncology
All 16 trial sites are open for recruitment, with 146 patients included and 134 randomized as of 31 August 2026
Read the latest updates from the IMPORTANT project
important-project.com
#IMPORTANTProject #HorizonEurope #BreastCancer #ClinicalTrials #GeriatricOncology